168 related articles for article (PubMed ID: 19751224)
1. Photopheresis in pediatric patients with low-body weight using the UVAR XTS system.
Hillen U; Meyer S; Schadendorf D; Kremens B
J Dtsch Dermatol Ges; 2010 Jan; 8(1):32-7. PubMed ID: 19751224
[TBL] [Abstract][Full Text] [Related]
2. The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low-weight children: a novel procedure.
Schneiderman J; Jacobsohn DA; Collins J; Thormann K; Kletzel M
J Clin Apher; 2010; 25(2):63-9. PubMed ID: 20301140
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
[TBL] [Abstract][Full Text] [Related]
4. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.
Liu C; Shah K; Dynis M; Eby CS; Grossman BJ
Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal photopheresis with permanent subcutaneous right atrial catheters.
Ständer H; Neugebauer F; Schneider SW; Luger TA; Schiller M
J Dtsch Dermatol Ges; 2007 Dec; 5(12):1112-8. PubMed ID: 17888008
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis in children with graft-versus-host disease.
Chan KW
J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229
[TBL] [Abstract][Full Text] [Related]
8. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F
Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
[TBL] [Abstract][Full Text] [Related]
9. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis for graft versus host disease: Identifying a clinical pathway and associated resource utilization.
Yerrabothala S; Talebian L; Klinker K; Hickman J; Hill JM; Hayes C; Lowrey C; Szczepiorkowski ZM; Meehan KR
J Clin Apher; 2018 Jun; 33(3):310-315. PubMed ID: 29193271
[TBL] [Abstract][Full Text] [Related]
11. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.
Bisaccia E; Vonderheid EC; Geskin L
Br J Dermatol; 2009 Jul; 161(1):167-9. PubMed ID: 19298276
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments.
Chionis L; Grossman BJ; Hachem R; Commean P; Derfler MC; Vedantham S; Dodds K; Spitznagel E; Atkinson J; Despotis G
Transfusion; 2018 Dec; 58(12):2933-2941. PubMed ID: 30312482
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the CELLEX™ and UVAR-XTS™ closed-system extracorporeal photopheresis devices in the treatment of chronic graft-versus-host disease.
Whittle RM; Denney H; Chantry AD; Alfred A; Taylor PC
J Clin Apher; 2017 Dec; 32(6):462-473. PubMed ID: 28608529
[TBL] [Abstract][Full Text] [Related]
14. The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD).
Afzal A; Tarbunova M; Despotis G; Grossman BJ
Transfusion; 2020 Feb; 60(2):351-357. PubMed ID: 31919871
[TBL] [Abstract][Full Text] [Related]
15. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance.
Kusztal M; Kłak R; Krajewska M; Boratyńska M; Patrzałek D; Klinger M
Transplant Proc; 2011 Oct; 43(8):2941-2. PubMed ID: 21996195
[TBL] [Abstract][Full Text] [Related]
16. Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD.
González Vicent M; Ramirez M; Sevilla J; Abad L; Díaz MA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):589-93. PubMed ID: 20962677
[TBL] [Abstract][Full Text] [Related]
17. The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients.
Rangarajan HG; Punzalan RC; Camitta BM; Talano JA
Br J Haematol; 2013 Nov; 163(3):357-64. PubMed ID: 23961954
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients.
Kanold J; Paillard C; Halle P; D'Incan M; Bordigoni P; Deméocq F
Transfus Apher Sci; 2003 Feb; 28(1):71-80. PubMed ID: 12620271
[TBL] [Abstract][Full Text] [Related]
19. Intensive extracorporeal photochemotherapy in pediatric patients with chronic graft-versus-host disease (cGVHD).
Duzovali O; Chan KW
Pediatr Blood Cancer; 2007 Feb; 48(2):218-21. PubMed ID: 16628538
[TBL] [Abstract][Full Text] [Related]
20. Update on the mechanism of action and on clinical efficacy of extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease in children.
Goussetis E; Varela I; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):203-9. PubMed ID: 22079263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
